Total Payments
$15,584
2024 Payments
$642.99
Companies
36
Transactions
151
Medicare Patients
818
Medicare Billing
$92,723
Payment Breakdown by Category
Food & Beverage$15,563 (99.9%)
Education$20.52 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,563 | 149 | 99.9% |
| Education | $20.52 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,096 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,661 | 15 | $0 (2023) |
| Amgen Inc. | $1,169 | 11 | $0 (2021) |
| AbbVie Inc. | $1,074 | 10 | $0 (2021) |
| Abbott Laboratories | $1,000 | 10 | $0 (2024) |
| Medtronic Vascular, Inc. | $886.44 | 10 | $0 (2020) |
| PFIZER INC. | $775.82 | 7 | $0 (2019) |
| Esperion Therapeutics, Inc. | $596.29 | 5 | $0 (2022) |
| Amarin Pharma Inc. | $589.91 | 7 | $0 (2019) |
| Merck Sharp & Dohme LLC | $578.96 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $642.99 | 5 | Janssen Pharmaceuticals, Inc ($385.04) |
| 2023 | $1,129 | 10 | Boston Scientific Corporation ($249.13) |
| 2022 | $1,828 | 16 | AstraZeneca Pharmaceuticals LP ($442.66) |
| 2021 | $1,180 | 11 | Amgen Inc. ($290.39) |
| 2020 | $649.60 | 7 | Janssen Pharmaceuticals, Inc ($218.29) |
| 2019 | $3,260 | 32 | Janssen Pharmaceuticals, Inc ($461.10) |
| 2018 | $2,214 | 22 | Janssen Pharmaceuticals, Inc ($241.55) |
| 2017 | $4,680 | 48 | Medtronic Vascular, Inc. ($676.22) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $127.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $127.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $106.72 | General |
| 03/12/2024 | Abbott Laboratories | ENSITE PRECISION (Device) | Food and Beverage | In-kind items and services | $151.23 | General |
| Category: Electrophysiology | ||||||
| 02/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $130.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/25/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $113.18 | General |
| Category: LUX-Dx_CRM | ||||||
| 08/03/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $96.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/02/2023 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: CARDIOLOGY | ||||||
| 06/14/2023 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $146.78 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 04/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $103.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2023 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $177.76 | General |
| Category: CARDIOLOGY | ||||||
| 02/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $105.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $111.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/19/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $135.95 | General |
| Category: General - Therapies_CRM | ||||||
| 01/09/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/17/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $123.74 | General |
| Category: Diabetes Care | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/22/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $96.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/25/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $105.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/28/2022 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $104.73 | General |
| Category: Genetic Disease | ||||||
| 07/21/2022 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/01/2022 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $120.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/26/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $104.98 | General |
| Category: Diabetes | ||||||
| 05/17/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $85.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $114.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 78 | 252 | $26,145 | $18,570 |
| 2022 | 4 | 174 | 417 | $37,030 | $26,575 |
| 2021 | 5 | 257 | 454 | $35,120 | $25,969 |
| 2020 | 6 | 309 | 512 | $33,982 | $21,609 |
Total Patients
818
Total Services
1,635
Medicare Billing
$92,723
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 233 | $24,780 | $17,510 | 70.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 19 | $1,365 | $1,060 | 77.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 253 | $26,923 | $19,444 | 72.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 109 | $7,864 | $5,936 | 75.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 14 | 14 | $1,400 | $796.88 | 56.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 38 | 41 | $842.81 | $398.40 | 47.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 207 | $22,046 | $16,706 | 75.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 123 | $8,835 | $6,733 | 76.2% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 53 | 56 | $1,817 | $1,274 | 70.2% |
| 93922 | Ultrasound study of arteries of both arms and legs, limited | Office | 2021 | 13 | 13 | $1,300 | $711.96 | 54.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 52 | 55 | $1,123 | $543.40 | 48.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 86 | 181 | $19,277 | $12,137 | 63.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 156 | $11,240 | $7,360 | 65.5% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 57 | 64 | $2,076 | $1,280 | 61.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 56 | 59 | $1,204 | $652.33 | 54.2% |
| 81002 | Urinalysis, manual test | Office | 2020 | 27 | 27 | $97.20 | $92.77 | 95.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2020 | 25 | 25 | $87.50 | $86.45 | 98.8% |
About Dr. David Smith, MD
Dr. David Smith, MD is a Medical Genetics, Ph.D. Medical Genetics healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124175542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Smith, MD has received a total of $15,584 in payments from pharmaceutical and medical device companies, with $642.99 received in 2024. These payments were reported across 151 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($15,563).
As a Medicare-enrolled provider, Smith has provided services to 818 Medicare beneficiaries, totaling 1,635 services with total Medicare billing of $92,723. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Genetics, Ph.D. Medical Genetics
- Other Specialties Ph.D. Medical Genetics
- Location Memphis, TN
- Active Since 01/05/2007
- Last Updated 07/08/2007
- Taxonomy Code 170100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124175542
Products in Payments
- XARELTO (Drug) $1,730
- FARXIGA (Drug) $967.48
- NEXLIZET (Drug) $596.29
- Vascepa (Drug) $589.91
- EUCRISA (Drug) $570.41
- Prolia (Biological) $504.99
- BREZTRI (Drug) $448.05
- Repatha (Biological) $445.98
- INVOKANA (Drug) $365.82
- Livalo (Drug) $338.52
- JARDIANCE (Drug) $337.94
- ClosureFast (Device) $330.86
- Veltassa (Drug) $323.15
- ELIQUIS (Drug) $301.06
- BELSOMRA (Drug) $291.94
- CRT-Ds (Device) $275.93
- HawkOne (Device) $246.79
- Resolute (Device) $242.21
- Ozempic (Drug) $226.55
- TRELEGY ELLIPTA (Drug) $221.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.